Dementia with Lewy bodies (DLB) is a complex condition that shares features with both Alzheimer’s disease and Parkinson’s ...
HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.
ZUNVEYL (benzgalantamine) is a twice-daily treatment designed to address the cognitive symptoms of mild-to-moderate Alzheimer’s disease. By enhancing cholinergic function in the brain, ZUNVEYL ...
CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...
A recent trial on gantenerumab showed that the drug could reduce the risk of Alzheimer’s symptoms by 50% in pre-symptomatic ...
In Kenya, the Alzheimer’s and Dementia Organisation Kenya (ADOK) estimates that around 60,000 people are affected, a number ...
Desjardins Securities analyst Gary Ho sees TerraVest Industries Inc. ’s ( N/A ) US$546-million acquisition of EnTrans International as “transformative” and puts “an under-levered balance sheet to work ...
Organizers said they hope to empower seniors to improve balance, alleviate pain and stiffness and increase confidence.
"The global industry was valued at US$ 37.0 Bn in 2023 and is projected to reach US$ 64.8 Bn by 2034, growing at a CAGR of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback